24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
23andMe
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
17:55
"We won’t give up on Israeli high-tech"
17:44
"The best advice I can give to small companies considering going public is to wait as long as possible"
15:08
"In Israel, as in New York, entrepreneurs need a strong ecosystem"
14:35
"Throughout my career, I was often the only woman in the room"
More stories
Buzz
Most popular
Daily
Weekly
1
Intel CEO Lip-Bu Tan: "We will remain focused" on cutting costs and complexity
2
a16z’s David Haber: “AI is making markets that weren’t attractive to software companies suddenly very compelling”
3
OpenAI raising $40 billion at a $300 billion valuation in record funding round
4
"We saved $350 million last year using AI agents"
5
The top 10 Israeli startups to watch out for in 2025
More news
23andMe
3 stories about 23andMe
23andMe’s downfall: From $3.5 billion IPO to bankruptcy filing
24.03.25
|
CTech and Reuters
A court-supervised sale is now the company’s best hope for the future.
CTech’s top 10 stories of 2024: A year in Israeli high-tech
01.01.25
|
CTech
The most-read articles this year reveal the triumphs, turmoil, and transformations shaping Israel’s tech landscape.
23andMe’s promise of genetic testing has been shattered
06.06.24
|
Viki Auslender
Three years have passed since the IPO of genetic testing company 23andMe and it has faced a nosedive in profits due to public mistrust, a one-time use product, ethical concerns about user data, and security breaches
